Healthcare Providers and Services
Company Overview of KEW Group LLC
KEW Group LLC provides DNA based genomic testing and interpretation services with evidence-based diagnostic and treatment pathways to oncology practices. The company offers Therapeutic Pathways, a platform for personalized medicine, which provides information about current and emerging therapies, and is deployed in Web-based format for oncology practitioners and other healthcare workers; and KEW CancerPlexSM symbol, a gene testing panel to evaluate genetic changes in a patient's tumor to help oncologists manage treatment options. It also provides molecular genetic testing services, which determine whether a particular individual is at risk to develop certain types of cancers or examination o...
790 Memorial Drive
Cambridge, MA 02139
Founded in 2009
Key Executives for KEW Group LLC
Chief Executive Officer, President and Director
Co-Founder and Chairman of the Board
Co-Founder, Director and Clinical Quality Board Chairman
Co-Founder and Board Observer
Compensation as of Fiscal Year 2015.
KEW Group LLC Key Developments
KEW Group Appoints Tom J. Miller as an Independent Director
Apr 12 15
KEW Group recently reported that Thomas (Tom) J. Miller, Jr. has joined its Board of Directors as an independent director. According to a release, a seasoned executive in the diagnostic space, Miller previously served as Chief Executive Officer (CEO) of Siemens Healthcare's Customer Solutions Division, responsible for an organization of 26,000 employees in more than 130 countries. He also held other leadership roles during his tenure at Siemens, including serving as a member of the Group Board of Siemens Medical Solutions, as well as overseeing the company's global MRI business. In addition to his leadership roles with Siemens, Miller has served as CEO for several other organizations, including Global Medical Operations of Carl Zeiss Inc.; Analogic Corp.; and LightLab Imaging, a start-up he helped to establish and sell, and for whom he also served as Chairman. In April 2013, he founded GreyBird Ventures, a consultancy and investment firm, where he currently serves as director, advisor, and/or investor in six healthcare start-up companies.
KEW Group Inc. Appoints Thomas (Tom) J. Miller, Jr. to its Board of Directors as an Independent Director
Apr 1 15
KEW Group Inc. announced that Thomas (Tom) J. Miller, Jr. has joined its Board of Directors as an independent director. A seasoned executive in the diagnostic space, Mr. Miller previously served as Chief Executive Officer (CEO) of Siemens Healthcare’s Customer Solutions Division, responsible for an organization of 26,000 employees in more than 130 countries. He also held other leadership roles during his tenure at Siemens, including serving as a member of the Group Board of Siemens Medical Solutions, as well as overseeing the company’s global MRI business.
Cardinal Health Specialty Solutions, KEW Group Bring Power of Personalized Medicine to Community Oncologists
Sep 29 14
Cardinal Health Specialty Solutions and KEW Group Inc. announced an agreement for the two companies to make KEW's diagnostic services available to Specialty Solutions' community oncology customers. Cardinal Health Specialty Solutions customers will now have access to KEW's CancerPlex. CancerPlex: Simultaneously provides complete sequence coverage of more than 410 cancer genes; Simplifies and streamlines the test-ordering process by eliminating serial "hotspot" tests; Delivers a comprehensive report, including actionable data; Informs physicians of optimal treatment options using approved therapies and available clinical trials; and Supports clinical trial enrollment by providing oncologists with required molecular data.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 5, 2014